FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 69729-133-27 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 69729-322-37 | OPMX LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE; ACETAMINOPHEN | 69729-223-02 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DOXYLAMINE SUCCINATE; DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 69729-054-10 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN; GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE | 69729-143-72 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN; DOXYLAMINE SUCCINATE | 69729-003-10 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
PYRILAMINE MALEATE; CAFFEINE; ACETAMINOPHEN | 69729-146-22 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
PYRILAMINE MALEATE; CAFFEINE; ACETAMINOPHEN | 69729-132-06 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 69729-068-02 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
CHLORPHENIRAMINE MALEATE; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 69729-323-38 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
CHLORPHENIRAMINE MALEATE; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 69729-222-06 | OPMX LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CAFFEINE; ACETAMINOPHEN; PYRILAMINE MALEATE | 69729-145-22 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 69729-142-06 | OPMX LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE; ACETAMINOPHEN | 69729-223-38 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 69729-122-38 | OPMX LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
PYRILAMINE MALEATE; ACETAMINOPHEN; CAFFEINE | 69729-131-72 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 69729-159-12 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE | 69729-154-24 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 69729-133-06 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 69729-107-40 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ACETAMINOPHEN | 69729-149-24 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
PYRILAMINE MALEATE; ACETAMINOPHEN; CAFFEINE | 69729-144-22 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ACETAMINOPHEN | 69729-147-40 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 69729-122-27 | OPMX LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
PYRILAMINE MALEATE; ACETAMINOPHEN; CAFFEINE | 69729-131-50 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 69729-105-24 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
CHLORPHENIRAMINE MALEATE; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 69729-222-37 | OPMX LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 69729-133-38 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; ACETAMINOPHEN | 69729-057-10 | OPMX LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 69729-155-06 | OPMX LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
-